相关实验视频

Updated: Jan 10, 2026

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

A Human Peripheral Blood Mononuclear Cell PBMC Engrafted Humanized Xenograft Model for Translational Immuno-oncology I-O Research

Published on: August 15, 2019

利用IgM用于固体瘤治疗:生物学,工程进步和翻译挑战

Yuhui Wang^1,2,3, Bing Wang⁴, Shuhan Liu³

¹Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.

Frontiers in immunology

|November 21, 2025

概括

免疫球蛋白M (IgM) 抗体为癌症免疫疗法提供了独特的优势,显示出对固体瘤的承诺. 克服发展中的挑战可能会导致新的基于IgM的癌症治疗方法.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

免疫球蛋白M (IgM) 抗体正在成为癌症免疫治疗的有希望的下一代平台.
与IgG相比,IgM提供了明显的生物学优势,包括更高的慕度,强大的补充激活,以及在免疫抑制环境中更好地识别各种瘤抗原.

研究的目的:

审查固体瘤治疗IgM抗体的结构,生物学和治疗潜力.
突出工程新型IgM格式的进步,并讨论翻译挑战和机遇.

主要方法:

关于IgM抗体在癌症免疫治疗中的当前科学文献的综述.
对工程IgM格式的临床前和早期翻译研究的分析.
检查IgM开发的结构,生物物理和制造方面的考虑.

主要成果:

工程IgM格式在临床前模型中显示出显著的抗瘤潜力.
在固体瘤中,IgM的多价值结合,补体激活和抗原识别具有优势.
关键的挑战包括短血清半衰期,瘤透,复杂性和生产可扩展性.

结论:

IgM 抗体在固体瘤治疗中具有显著的治疗前景.
需要进一步的研究和开发,以克服临床应用的翻译障碍.
IgM 是未来基于抗体的癌症免疫疗法的潜在基石.

关键词:

的IgM IgM 的情况.抗体疗法是一种抗体疗法.临床翻译临床翻译免疫疗法免疫疗法固体瘤是一个固体瘤.

更多相关视频

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Molecular and Immunologic Techniques in a Genetically Engineered Mouse Model of Gastrointestinal Stromal Tumor

Published on: May 2, 2022

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...